Onc.AI: Funding, Investors & Team (Oct 2026)
Onc.AI is venture-capital backed company committed to developing robust, clinically validated, imaging-AI powered clinical management solutions focused on immunotherapy optimization. Using patented, radiomic-based AI models, Onc.AI has developed a clinical decision support platform using routine diagnostic imaging scans specifically for planning and guidance of first-line immune checkpoint inhibitors (ICI) treatment plans.
Onc.AI has raised $33.0M across 3 funding rounds on record, the most recent an undisclosed round of $2.0M announced in Oct 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Onc.AI Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Onc.AI Funding Rounds
Onc.AI raised $6.0M in an undisclosed round announced in Dec 2020.
2.1 years later, a Series A of $25.0M was announced in Jan 2023.
1.8 years later, an undisclosed round of $2.0M was announced in Oct 2024.
Onc.AI Founders and Leadership Team
Contact details for the Onc.AI team: 2 of 2 have an email address on file.
Start 14-day free trial →Onc.AI Funding Compared to Other Biotechnology Startups
Onc.AI's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Onc.AI in Biotechnology and San Carlos
Companies Similar to Onc.AI
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Onc.AI Funding FAQs
What does Onc.AI do?
Onc.AI is venture-capital backed company committed to developing robust, clinically validated, imaging-AI powered clinical management solutions focused on immunotherapy optimization. Using patented, radiomic-based AI models, Onc.AI has developed a clinical decision support platform using routine diagnostic imaging scans specifically for planning and guidance of first-line immune checkpoint inhibitors (ICI) treatment plans.
How much funding has Onc.AI raised?
Onc.AI has raised $33.0M across 3 rounds on record. The most recent is an undisclosed round of $2.0M announced in Oct 2024.
When did Onc.AI last raise funding?
Onc.AI's most recent funding round on record is an undisclosed round of $2.0M, announced in Oct 2024.
Who founded Onc.AI?
FundedIQ lists Salmaan Ahmed (Founder) at Onc.AI.
Who is the CEO of Onc.AI?
Akshay Nanduri is listed as CEO at Onc.AI.
Where is Onc.AI headquartered?
Onc.AI is based in San Carlos, California, United States.
How many employees does Onc.AI have?
Onc.AI is in the 11-50 employee band.
How does Onc.AI's funding compare to other Biotechnology startups?
Onc.AI's latest round of $2.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Onc.AI Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Onc.AI is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.